System and method for extraction and cryopreservation of bone marrow

Inventors

Woods, Erik John • Johnstone, Brian H. • GU, Dongsheng • Sherry, Aubrey Marie • Musall, Kelsey Gwen • Woods, John R. • Hardin, James • Hooks, Alan

Assignees

Ossium Health Inc

Interested in licensing this patent?

MTEC can help explore whether this patent might be available for licensing for your application.

Publication Number

US-11697799-B2

Patent

Publication Date

2023-07-11

Expiration Date


Abstract

Methods are provided for extracting bone marrow cells from bone obtained from deceased donors, for preparing the bone marrow for cryopreservation and for obtaining desired cells from cryopreserved and fresh bone marrow.

Core Innovation

The disclosure describes a method for manipulating environmental conditions of a cadaver or explanted bone and processing cadaver bone to recover stem cells comprising viable CD34+ cells. It identifies a relationship between cadaver bone ischemia conditions and the viability of recovered CD34+ cells and CFU output. The disclosure treats warm ischemia time and cold ischemia time as distinct periods relevant to cell viability, while the background problem is not explicitly described in patent.

The reported results demonstrate that CD34+ viability and CFU-Total output generally decline as warm or cold ischemia intervals lengthen, with prolonged intervals yielding zero CFU-Total. The disclosure further describes cadaveric bone-marrow extraction, processing, and cryobanking, identifying vertebral bodies and ilium as marrow sources. Operational timing limits and parameters are [procedural detail omitted for safety].

Claims Coverage

The provided claims identify one independent claim comprising three inventive features directed to manipulating cadaver environmental conditions and bone processing to recover viable CD34+ cells.

Manipulation of cadaver environmental conditions

The claim recites manipulating environmental conditions of a cadaver or explanted bone and processing cadaver bone for extraction of stem cells comprising CD34+ cells.

Distinct warm and cold ischemia periods

The claim defines warm ischemia time and cold ischemia time as distinct periods and constrains their relationship to support recovery of viable CD34+ cells, with detailed timing limits omitted for safety.

Viability of recovered CD34+ cells

The claim requires recovered CD34+ cells to meet a specified viability outcome and recites that fewer recovered CD34+ cells are viable when the stated ischemia timing conditions are exceeded.

The independent claim combines environmental-condition management and bone processing with a constrained timing relationship between distinct ischemia periods to achieve a specified viability outcome for recovered CD34+ cells.

Stated Advantages

The claim states that the method provides recovered CD34+ cells meeting a specified viability outcome.

The claim states that fewer recovered CD34+ cells are viable when the specified ischemia conditions are exceeded.

Documented Applications

Cadaveric bone-marrow extraction, processing, and cryobanking.

Recovery of stem cells, including CD34+ cells, from cadaver bone such as vertebral bodies and ilium.

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.